Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9984755 | 1.00 | P2RX7 (0.41) | P2RX7CYP2D6CYP2C19 | |
| SCHEMBL1698073 | 1.00 | P2RX7 (0.41) | P2RX7CYP2D6CYP2C19 | |
| SCHEMBL19381628 | 0.86 | P2RX7 (0.42) | P2RX7CYP2D6CYP2C19 | |
| SCHEMBL3901853 | 0.84 | P2RX7 (0.41) | P2RX7CYP2D6CYP2C19 | |
| SCHEMBL76783 | 0.84 | P2RX7 (0.41) | P2RX7CYP2D6CYP2C19 | |
| SCHEMBL12191694 | 0.84 | P2RX7 (0.41) | P2RX7CYP2D6CYP2C19 | |
| SCHEMBL5423530 | 0.84 | P2RX7 (0.41) | P2RX7CYP2D6CYP2C19 | |
| SCHEMBL32688678 | 0.84 | P2RX7 (0.41) | P2RX7CYP2D6CYP2C19 | |
| Hydrochloric Acid SCHEMBL3901856 | 0.82 | P2RX7 (0.40) | P2RX7CYP2D6CYP2C19 | |
| SCHEMBL7112807 | 0.82 | P2RX7 (0.40) | P2RX7CYP2D6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110308555-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE COMPANY, THE | 2011-12-22 | — | — | US | claimed |
| EP-3085759-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2018-02-07 | — | — | EP | disclosed |
| EP-3085759-A2 | PERFUME SYSTEMS | The Procter and Gamble Company (US) | 2016-10-26 | — | — | EP | disclosed |
| EP-2585569-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2016-08-24 | — | — | EP | disclosed |
| US-8609603-B2 | Perfume systems | THE PROCTER & GAMBLE COMPANY (US) | 2013-12-17 | — | — | US | disclosed |
| US-20110308555-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE COMPANY, THE | 2011-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110308555-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | P2RX7 246/4885CYP2D6 792/4885CYP2C19 354/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.